National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Nanodevices
< Back to Main
    Posted: 01/28/2005
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Slide 23 : Nanotechnologies in Patient Care previous

Nanotechnologies that will aid in cancer care are in various stages of discovery and development. Experts believe that quantum dots, nanopores, and other devices for detection and diagnosis may be available for clinical use in 5 to 15 years. Therapeutic agents are expected to be available within a similar time frame. Devices that integrate detection and therapy could be used clinically in about 15 or 20 years.

Nanotechnologies in Patient Care

< Previous  |  Index


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov